company background image
VIRP

Virbac ENXTPA:VIRP Stock Report

Last Price

€248.50

Market Cap

€2.0b

7D

-1.0%

1Y

-42.9%

Updated

09 Dec, 2022

Data

Company Financials +
VIRP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends0/6

VIRP Stock Overview

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa.

Virbac SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Virbac
Historical stock prices
Current Share Price€248.50
52 Week High€446.50
52 Week Low€228.00
Beta0.80
1 Month Change4.19%
3 Month Change-29.70%
1 Year Change-42.87%
3 Year Change10.69%
5 Year Change113.12%
Change since IPO1,922.29%

Recent News & Updates

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 25
Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Oct 14
Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Recent updates

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 25
Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Oct 14
Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

Aug 07
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Jun 26
These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

May 01
Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Mar 26
We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Jan 26
Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Dec 28
Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Oct 27
A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Is Virbac (EPA:VIRP) Using Too Much Debt?

Oct 12
Is Virbac (EPA:VIRP) Using Too Much Debt?

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Sep 26
Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Jul 15
Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Jun 27
Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Is Virbac (EPA:VIRP) A Risky Investment?

May 27
Is Virbac (EPA:VIRP) A Risky Investment?

Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Mar 24
Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Mar 12
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Feb 22
Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Feb 03
Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 05
Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Dec 18
Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Estimating The Fair Value Of Virbac SA (EPA:VIRP)

Dec 01
Estimating The Fair Value Of Virbac SA (EPA:VIRP)

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Nov 18
Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Shareholder Returns

VIRPFR PharmaceuticalsFR Market
7D-1.0%1.3%-1.4%
1Y-42.9%4.4%-7.1%

Return vs Industry: VIRP underperformed the French Pharmaceuticals industry which returned 5.8% over the past year.

Return vs Market: VIRP underperformed the French Market which returned -7.1% over the past year.

Price Volatility

Is VIRP's price volatile compared to industry and market?
VIRP volatility
VIRP Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement5.2%
10% most volatile stocks in FR Market11.1%
10% least volatile stocks in FR Market2.7%

Stable Share Price: VIRP is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: VIRP's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19685,120Sebastien Huronhttps://corporate.virbac.com

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners.

Virbac SA Fundamentals Summary

How do Virbac's earnings and revenue compare to its market cap?
VIRP fundamental statistics
Market Cap€2.03b
Earnings (TTM)€118.70m
Revenue (TTM)€1.15b

17.7x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VIRP income statement (TTM)
Revenue€1.15b
Cost of Revenue€389.60m
Gross Profit€761.32m
Other Expenses€642.62m
Earnings€118.70m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)14.05
Gross Margin66.15%
Net Profit Margin10.31%
Debt/Equity Ratio14.3%

How did VIRP perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

9%

Payout Ratio